Named on one round in the feed.
Since 2016-06-28
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
STORM Therapeutics STORM Therapeutics develops RNA modifying enzyme inhibitors for the treatment of sarcomas. | Series A Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $16.1M | 2016-06-28 | [ PART ] |